Mu Qingchun, Zhang Yufei, Cheng Qian, Huang Hanning, Huang Chunming, Tang Longguang
Department of Neurosurgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, China.
Department of Neurosurgery, The People's Hospital of Gaozhou, Maoming, China.
Ann Transl Med. 2022 Jul;10(14):806. doi: 10.21037/atm-22-3136.
Ischemic cerebrovascular disease is one of the main diseases threatening human health and survival and is a commonly occurring disease in neurology. Due to its high disability rate, ischemic cerebrovascular disease is one of the most important diseases to be prevented and treated at present. The risk factors of cerebral ischemia include atherosclerosis, hypertension, hyperlipidemia, and blood viscosity caused by thrombocytosis. After cerebral ischemia, cerebral ischemia-reperfusion injury may be induced by oxidative stress (OS), inflammatory reaction, nitric oxide damage, apoptosis, excitatory amino acid toxicity, calcium (Ca) overload, and other mechanisms. Hesperidin is a flavanone compound and is a key component in citrus plants. It is a kind of traditional Chinese medicine extract with high levels of Pericarpium, shell, fruit, and green peel. In recent years, Hesperidin has received great attention, compelling evidence has indicated Hesperidin plays a beneficial role in cerebral ischemia.
We conducted a literature search for published manuscripts hesperidin in ischemia/reperfusion up to December 2021 in common English databases (i.e., PubMed, EMBASE, Web of Science, SpringerLink, Wiley, Cochrane Library) and Chinese databases [Chinese BioMedical Literature Service System (CBM), WANFANG database, China Knowledge Resource Integrated Database (CNKI)].
In this article, we reviewed the mechanisms of action of hesperidin in the treatment of cerebral ischemia, including antioxidant stress, anti-inflammatory reaction, anti-atherosclerosis, anti-thrombosis, anti-apoptosis, and nitric oxide regulation.
In this narrative review, Hesperidin exhibits antioxidant stress, anti-platelet aggregation, vasodilation, anti-atherosclerotic, anti-inflammatory, anti-apoptotic, hypolipidemic, anti-tumor, cardiovascular protection, and nitric oxide-release regulatory properties Such a comprehension of the recent progress of hesperidin will help identify biomarkers for diagnosis and therapeutic targets to cerebral ischemia.
缺血性脑血管病是威胁人类健康与生存的主要疾病之一,是神经内科的常见疾病。由于其高致残率,缺血性脑血管病是目前最重要的防治疾病之一。脑缺血的危险因素包括动脉粥样硬化、高血压、高脂血症以及血小板增多症导致的血液黏稠度增加。脑缺血后,氧化应激(OS)、炎症反应、一氧化氮损伤、细胞凋亡、兴奋性氨基酸毒性、钙(Ca)超载等机制可能诱发脑缺血再灌注损伤。橙皮苷是一种黄酮类化合物,是柑橘类植物中的关键成分。它是一种富含陈皮、外壳、果实和青皮的中药提取物。近年来,橙皮苷受到了广泛关注,有力的证据表明橙皮苷在脑缺血中发挥有益作用。
我们在常见的英文数据库(即PubMed、EMBASE、Web of Science、SpringerLink、Wiley、Cochrane Library)和中文数据库[中国生物医学文献服务系统(CBM)、万方数据库、中国知网(CNKI)]中检索了截至2021年12月发表的关于橙皮苷在缺血/再灌注中的手稿。
在本文中,我们综述了橙皮苷治疗脑缺血的作用机制,包括抗氧化应激、抗炎反应、抗动脉粥样硬化、抗血栓形成、抗细胞凋亡和一氧化氮调节。
在这篇叙述性综述中,橙皮苷具有抗氧化应激、抗血小板聚集、血管舒张、抗动脉粥样硬化、抗炎、抗细胞凋亡、降血脂、抗肿瘤、心血管保护和一氧化氮释放调节特性。对橙皮苷最新进展的这种理解将有助于确定脑缺血诊断的生物标志物和治疗靶点。